MacLeod, Angus D.Goddard, HannahCounsell, Carl E.2016-05-262016-05-262016-07MacLeod, A D, Goddard, H & Counsell, C E 2016, 'Co-morbidity burden in Parkinson’s disease : Comparison with controls and its influence on prognosis', Parkinsonism & Related Disorders, vol. 28, pp. 124-129. https://doi.org/10.1016/j.parkreldis.2016.05.0131353-8020ORCID: /0000-0001-6622-7839/work/164505628ORCID: /0000-0002-6284-4239/work/191926801http://hdl.handle.net/2164/6015Financial support This study was funded by Parkinson’s UK, the Scottish Chief Scientist Office, NHS Grampian endowments, the BMA Doris Hillier award, RS Macdonald Trust, the BUPA Foundation, and SPRING. The funders had no involvement in the study. Acknowledgements We acknowledge funding for the PINE study from Parkinson’s UK (G-0502, G-0914, G-1302), the Scottish Chief Scientist Office(CAF/12/05), the BMA Doris Hillier award, RS Macdonald Trust, the BUPA Foundation, NHS Grampian endowments and SPRING. We thank the patients and controls for their participation and the research staff who collected data and supported the study database.6222091930242320594755engParkinson’s diseaseco-morbidityCharlsonmortalitydependencyRC Internal medicineParkinson's UKG-0502G-0914G-1302Chief Scientist Office (CSO)CAF/12/05RCJournal article10.1016/j.parkreldis.2016.05.01328